Woodline Partners »

Bowhead Specialty Hldgs shares owned by Woodline Partners

Quarter-by-quarter ownership of Bowhead Specialty Hldgs (BOW) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Bowhead Specialty Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Bowhead Specialty Hldgs held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bowhead Specialty Hldgs by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $868k 31k 28.01
2024-06-30 $1.6M 62k 25.34

More positions owned by Woodline Partners

Meta Platforms Cl A (META)
Gilead Sciences (GILD)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Asml Holding N V N Y Registry Shs (ASML)
Nuvalent Inc-a (NUVL)
Permian Resources Corp Class A Com (PR)
Encana Corporation (OVV)
Keysight Technologies (KEYS)
Danaher Corporation (DHR)
Aon Shs Cl A (AON)
Stmicroelectronics N V Ny Registry (STM)
Regeneron Pharmaceuticals (REGN)
EQT Corporation (EQT)

View all positions for Woodline Partners

Top funds holding Bowhead Specialty Hldgs

American Family Investments
T. Rowe Price Associates
American Century Companies
Victory Capital Management
BlackRock
Balyasny Asset Management
Daniel D. Thurber
Driehaus Capital Management
T. Rowe Price Investment Management
Emerald Advisers
Lord, Abbett & Co
Next Century Growth Investors
Zimmer Partners
Emerald Mutual Fund Advisers, Trust
Geode Capital Management

View all funds holding Bowhead Specialty Hldgs